Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score

Journal of Cachexia, Sarcopenia and Muscle

Volumn 8, Issue 1, 2017, Pages 113-121

  Kalafateli, Maria ^a   Mantzoukis, Konstantinos ^a   Choi Yau, Yan ^a   Mohammad, Ali O ^a,b   Arora, Simran ^a   Rodrigues, Susana ^a   de Vos, Marie ^a   Papadimitriou, Kassiani ^a   Thorburn, Douglas ^a   O'Beirne, James ^a   Patch, David ^a   Pinzani, Massimo ^a   Morgan, Marsha Y ^a   Agarwal, Banwari ^a   Yu, Dominic ^a   Burroughs, Andrew K ^a   Tsochatzis, Emmanuel A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b MINIA UNIVERSITY   (Egypt)

Author keywords

Cirrhosis; Morbidity; Mortality; Nutritional assessment; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; L3 PSOAS MUSCLE INDEX; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; MUSCULOSKELETAL SYSTEM PARAMETERS; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; ROYAL FREE HOSPITAL GLOBAL ASSESSMENT; SARCOPENIA; SCORING SYSTEM; SURGICAL MORTALITY; DIAGNOSTIC IMAGING; INFECTION; LENGTH OF STAY; LIVER DISEASE; MIDDLE AGED; ODDS RATIO; SEVERITY OF ILLNESS INDEX; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; INFECTION; INTENSIVE CARE UNITS; LENGTH OF STAY; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; ODDS RATIO; PREVALENCE; RESPIRATION, ARTIFICIAL; SARCOPENIA; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84958206223     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12095     Document Type: Article

References (34)

1. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet 2014;383:1749–1761.
2. Cabre E, Gassull MA. Nutrition in liver disease. Curr Opin Clin Nutr Metab Care 2005;8:545–551.
3. Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol: the official clinical practice journal of the American Gastroenterological Association 2012;10:117–125.
4. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia–anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010;29:154–159.
5. Carvalho L, Parise ER. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006;43:269–274.
6. Sam J, Nguyen GC. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int: official journal of the International Association for the Study of the Liver 2009;29:1396–1402.
7. Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, McPhail MJ, et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014;20:54–62.
8. Johnson TM, Overgard EB, Cohen AE, DiBaise JK. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract: official publication of the American Society for Parenteral and Enteral Nutrition 2013;28:15–29.
9. Moctezuma-Velazquez C, Garcia-Juarez I, Soto-Solis R, Hernandez-Cortes J, Torre A. Nutritional assessment and treatment of patients with liver cirrhosis. Nutrition 2013;29:1279–1285.
10. Montano-Loza AJ. Muscle wasting: a nutritional criterion to prioritize patients for liver transplantation. Curr Opin Clin Nutr Metab Care 2014;17:219–225.
11. Morgan MY, Madden AM, Soulsby CT, Morris RW. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology 2006;44:823–835.
12. Gunsar F, Raimondo ML, Jones S, Terreni N, Wong C, Patch D, et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006;24:563–572.
13. Cruz RJ Jr, Dew MA, Myaskovsky L, Goodpaster B, Fox K, Fontes P, et al. Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation 2013;95:617–622.
14. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008;9:629–635.
15. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol: the official clinical practice journal of the American Gastroenterological Association 2012;10:166–173, 73 e1.
16. Durand F, Buyse S, Francoz C, Laouenan C, Bruno O, Belghiti J, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol 2014;60:1151–1157.
17. Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012;18:1209–1216.
18. Krell RW, Kaul DR, Martin AR, Englesbe MJ, Sonnenday CJ, Cai S, et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013;19:1396–1402.
19. Montano-Loza AJ, Meza-Junco J, Baracos VE, Prado CM, Ma M, Meeberg G, et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014;20:640–648.
20. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9:970–981.
21. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008;57:252–257.
22. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
23. Mendenhall CL. Protein-calorie malnutrition in alcoholic liver disease. In Watson RR, Watzl B, eds. Nutrition and Alcohol. Boca Raton, FL: CRC Press; 1992. p363–384.
24. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010;211:271–278.
25. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging 2009;13:724–728.
26. Visser M. Towards a definition of sarcopenia—results from epidemiologic studies. J Nutr Health Aging 2009;13:713–716.
27. Rohrbach J, Stickel F, Schmid P, Thormann W, Kovari H, Scherrer A, et al. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals. Antivir Ther 2014;19:149–159.
28. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–649.
29. Gonzalez FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994;20:565–573.
30. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6:783–790.
31. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802–810.
32. Merli M, Giusto M, Gentili F, Novelli G, Ferretti G, Riggio O, et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int: official journal of the International Association for the Study of the Liver 2010;30:208–214.
33. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003;19:515–521.
34. Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic paradigm for patients with cirrhosis. Hepatology 2012;56:1983–1992.